The treatment of Tessier no. 3 and no. 4 clefts is controversial, and little is published because of their rarity. Frequently, many surgeries are necessary for correction of these defects, and in some cases, the outcomes are less than the ideal. Aware of that problem, we developed a procedure based on the Van der Meulen rotation and advancement flap of the cheek that may correct the cleft with 1 simple procedure and also respects the aesthetic units of the face. We report 3 patients presenting cleft no. 3 and 1 patient presenting cleft no. 4 and describe the rotation and advancement flap of the cheek technique used in their treatment.

No abstract

Background:There are studies demonstrating an increased expression of cyclooxygenase (COX) in keloids and hypertrophic scars, suggesting that anti-inflammatory drugs could be used in their treatment. However, a precise relationship between COX and pathological scarring has not been established in the literature yet. This study aims to evaluate the immunohistochemical expression of COXs in these scars.Methods:Prospective study, including 54 patients (aged 18–60 years) undergoing scar excision: 18 normal scars (group 1), 18 hypertrophic scar (group 2), and 18 keloids (group 3). The group classification was performed by clinical criteria. Scars samples were collected and anatomopathological examination (through hematoxylin-eosin method) was performed to confirm the scar type. Immunohistochemistry was performed to assess the expression of COX1 and COX2 in epidermis and dermis. Results were compared among all groups and between group I versus II and III together (abnormal scars).Results:For COX1, in the epidermis, there was no significant difference in the immunohistochemical expression when comparing the 3 groups. In the dermis, groups 2 and 3 had greater expression than group 1, with a significant difference being found when comparing all groups (P = 0.014), and in the comparison between normal versus abnormal scars (P = 0.004). For COX2, there was no significant difference between the groups in both the epidermis and dermis.Conclusions:The immunohistochemical expression of COX1 was greater in the dermis of abnormal scars when compared with normal scars. Future studies can be performed involving COX blockade as a perspective of these scars treatment.

Os autores estudaram as alterações enzimáticas [transaminase oxalo-acética (TGO), creatinofosfoquinase (CPK) e desidrogenase lática (LDH)] decorrentes de isquemia muscular esquelética em ratos submetidos à isquemia de membro inferior por 0, 2, 4 e 6 horas. Vinte e oito ratos Wistar foram divididos em 4 grupos: Grupo I (controle); e Grupos II, III, e IV (isquemia por 2, 4 e 6 horas, respectivamente). Após o período de isquemia, foi coletado sangue do plexo retrocular para análise laboratorial. Os valores obtidos (média±desvio padrão) para TGO nos Grupos I, II, III e IV foram, respectivamente: 20,14±6,76; 59,71±28,91; 88,28±11,17 e 123±52,65 U/l. Para CPK, os valores foram: 67,85±62,76; 203±108,71; 237,71±95,06 e 291,71±173,19 U/l. Para LDH, obteve-se: 334,14±117,13; 414,42±222,47; 526±234,75 e 427,57±273,58 U/l. Para análise estatística, utilizou-se o método de ANOVA, seguido do teste t de Bonferroni (p<0,05). Os níveis de TGO foram significativamente superiores nos grupos III e IV quando comparados ao controle. Para CPK, houve distinção significativa entre os grupos IV e I. Os níveis de LDH não se demonstraram estatisticamente diferentes entre os grupos. Os autores concluem que em períodos de isquemia por 2, 4 e 6 horas, a dosagem de LDH não se mostra um parâmetro útil na avaliação de dano muscular esquético. A TGO e CPK tiveram alterações significativas a partir de 4 e 6 horas, respectivamente, mostrando-se úteis na avaliação de isquemia muscular em ratos.